Cascades Inc. delivered a strong Q4 2025 performance with adjusted EBITDA up 9% year-over-year to CAD 155 million, driven by operational improvements and cost controls. The company swung to net earnings of CAD 0.37 per share from a prior-year loss, reduced net debt significantly, and maintained a quarterly dividend. Full-year adjusted EBITDA rose 15% to CAD 576 million, though sales dipped slightly amid sector challenges, particularly in tissue. Management emphasized strategic debt reduction and ongoing efficiency initiatives.
Cascades Q4 2025 Earnings Call Highlights
Cascades Inc., the Canadian packaging and tissue producer, reported its fourth quarter and full-year 2025 results during a recent earnings call, showcasing a notable recovery in profitability despite ongoing market headwinds. The company highlighted sequential and year-over-year improvements in key profitability metrics, fueled by disciplined cost management, operational enhancements, and favorable input cost dynamics in certain areas.
In the fourth quarter, consolidated sales reached CAD 1,197 million, down from CAD 1,211 million in the same period of 2024 and CAD 1,238 million in the third quarter of 2025. This modest decline reflected softer demand in some segments and pricing pressures, particularly in the tissue sector, which faced competitive dynamics and volume softness.
Despite the top-line softness, profitability showed clear strength. Operating income climbed to CAD 76 million, a significant improvement from CAD 16 million in Q4 2024 and up from CAD 73 million in the prior quarter. Adjusted EBITDA stood at CAD 155 million, marking a 9% increase from CAD 146 million a year earlier, though slightly below the CAD 159 million recorded in Q3 2025. The margin expansion to approximately 12.9% overall was led by robust performance in the packaging sector, where margins reached 17.4%.
Net earnings attributable to common shareholders improved markedly to CAD 0.37 per share, compared to a net loss of CAD 0.13 per share in the prior-year quarter and CAD 0.29 in Q3 2025. Adjusted earnings per share came in at CAD 0.40, surpassing analyst expectations of around CAD 0.36 and reflecting a roughly 60% year-over-year increase on an adjusted basis.
A major focus during the call was the company’s successful deleveraging efforts. Cascades reduced its net debt by CAD 127 million in the fourth quarter alone, underscoring a strategic priority to strengthen the balance sheet amid higher interest rates and economic uncertainty. This contributed to improved financial flexibility and lower financing expenses, which decreased to CAD 32 million from CAD 34 million a year ago.
Full-year 2025 results provided additional context for the quarter’s performance. Consolidated sales totaled approximately CAD 4.8 billion, while adjusted EBITDA rose 15% to CAD 576 million, demonstrating the benefits of multi-year optimization programs, including raw material cost advantages in packaging and ongoing productivity gains across operations.
Segment performance varied. The packaging segment emerged as a standout, benefiting from improved margins and operational efficiencies that helped offset broader market challenges. In contrast, the tissue segment encountered difficulties, with lower volumes and pricing pressures weighing on results. Management noted that initiatives in tissue, including cost reductions and capacity adjustments, are progressing but have yet to fully counteract these headwinds.
During the question-and-answer portion of the call, executives addressed investor concerns around input costs, demand outlook, and capital allocation. They reiterated commitment to maintaining a stable dividend, with the Board declaring a quarterly payout of CAD 0.12 per common share, payable in late March 2026. Discussions also touched on sustainability efforts, ongoing investments in recycled content, and potential for further margin expansion as efficiency programs mature.
Looking ahead, leadership expressed cautious optimism, pointing to continued focus on debt reduction, operational excellence, and selective growth opportunities in sustainable packaging solutions. The company remains on track with targeted cost savings initiatives, having already realized meaningful contributions in recent quarters.
Key Financial Metrics Comparison (CAD millions, except per share)
| Metric | Q4 2025 | Q4 2024 | Q3 2025 | Full Year 2025 |
|---|---|---|---|---|
| Sales | 1,197 | 1,211 | 1,238 | ~4,800 |
| Operating Income | 76 | 16 | 73 | N/A |
| Adjusted EBITDA | 155 | 146 | 159 | 576 |
| Net Earnings per Share | 0.37 | (0.13) | 0.29 | N/A |
| Adjusted EPS | 0.40 | ~0.25 | N/A | N/A |
| Net Debt Reduction (Q4) | 127 | N/A | N/A | N/A |
Cascades continues to navigate a complex environment with resilience, prioritizing financial health and long-term value creation for shareholders.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial recommendations, or an endorsement of any security. Investors should conduct their own research and consult professional advisors before making decisions.
